description
Exogenous soluble antigens are cross-presented by dendritic cells, albeit with lower efficiency than for particulate substrates. Soluble antigens destined for cross-presentation are taken up by distinct endocytosis mechanisms which route them into stable early endosomes and then to the cytoplasm for proteasomal degradation and peptide loading

external resources
NCBI:1269199
REACTOME:R-HSA-1236978
PUBMED:15592474
PUBMED:20171863
PUBMED:17157489

genes
FCGR1A , FCGR1B , MRC1 , PSMA1 , PSMA2 , PSMA3 , PSMA4 , PSMA5 , PSMA6 , PSMA7 , PSMB1 , PSMB2 , PSMB3 , PSMB4 , PSMB5 , PSMB6 , PSMB7 , PSMB8 , PSMB9 , PSMB10 , PSMC1 , PSMC2 , PSMC3 , PSMC4 , PSMC5 , PSMC6 , PSMD1 , PSMD2 , PSMD3 , PSMD4 , PSMD5 , PSMD7 , PSMD8 , PSMD9 , PSMD10 , PSMD11 , PSMD12 , PSMD13 , PSME1 , PSME2 , SEM1 , PSMF1 , PSMD6 , MRC2 , PSME3 , PSMD14 , PSME4 , CD207 , PSMB11 , PSMA8 , C7orf76 , LOC100506136 ,